fda glp-1 enforcement news today Pipeline Update: November 2025 - Prime Therapeutics FDA cracks down on 'misleading'

Patients with diabetes or those taking insulin or sulfonylureas should consider checking blood glucose levels during episodes of tremor, palpitations, or sweating, as hypoglycemia can mimic anxiety symptoms

- Next gen foundation: GLP-1 drugs have already shown clinical success with huge revenue generation annually

Lancet 397:18301841 Shulman A, Peltonen M, Sjstrm CD et al (2018) Incidence of end-stage renal disease following bariatric surgery in the Swedish obese subjects study

The preferred site for most researchers due to consistent absorption and easy access

Oral semaglutide is $289/mo month-to-month (or $249/mo on the 6-month plan) and doesn't require refrigeration or injection training, making it practical for people with unpredictable schedules or needle anxiety